EUVIMEDEUVIMED entdecken
Crossref

Mouse Skin Inflammation Induced by Multiple Topical Applications of 12-O-Tetradecanoylphorbol-13-Acetate

P L Stanley, S Steiner, M Havens, K M Tramposch

Skin Pharmacology · 31.03.2009 · 262-271

DOI: 10.1159/000210960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Pharmacology, online erschienen am 31.03.2009. Verfasst von P L Stanley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bristol-Myers Squibb Pharmaceutical Research Institute, Buffalo, N.Y. Hauptthemen laut MEDLINE: Tetradecanoylphorbol Acetate. Die Arbeit wurde bisher 196-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is well known that applications of a single dose of 12-O-tetradecanoylphorbol-13-acetate (TPA) to mouse ears induces an acute inflammatory reaction consisting of erythema, edema and polymorphonuclear leukocyte (PMN) infiltration. We report here that multiple topical applications of TPA to mouse ears produce a prolonged inflammatory reaction characterized by increases in ear weight, inflammatory cell infiltration and epidermal hyperplasia. TPA was applied 5 times over 10 days to mouse ears. Epidermal thickness and PMN infiltration (myeloperoxidase content) increased 3- and 160-fold, respectively, by day 3 and remained elevated over control values throughout the test period. Ear weight was elevated from day 1 and remained high. Hydrocortisone 17-valerate and betamethasone dipropionate significantly reduced all three parameters of inflammation. Indomethacin and two other cyclo-oxygenase inhibitors, and an antihistamine had little or no effect on any of the parameters. This chronic skin inflammation model may be more relevant for evaluating anti-inflammatory compounds than the acute TPA model because the test compounds are applied after the inflammatory lesion is established, which mirrors the use of clinical anti-inflammatory drugs. Also this model may be more selective than the acute TPA model for compounds which affect leukotriene production since other pharmacological agents which are active in the acute model are not active in the multiple-application model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tetradecanoylphorbol AcetateAdministration, TopicalAnimalsAnti-Inflammatory AgentsDermatitis, ContactDisease Models, AnimalEar, ExternalEdemaFemaleHyperplasiaMiceMice, Inbred StrainsNeutrophilsSkinTime Factors

Substanzen

Anti-Inflammatory AgentsTetradecanoylphorbol Acetate

Autor:innen und Institutionen

  • Bristol-Myers Squibb Pharmaceutical Research Institute, Buffalo, N.Y.

Zitieren

APA

Stanley, P. L., Steiner, S., Havens, M., & Tramposch, K. M. (2009). Mouse Skin Inflammation Induced by Multiple Topical Applications of 12-O-Tetradecanoylphorbol-13-Acetate. Skin Pharmacology, 262-271. https://doi.org/10.1159/000210960

Vancouver

Stanley PL, Steiner S, Havens M, Tramposch KM. Mouse Skin Inflammation Induced by Multiple Topical Applications of 12-O-Tetradecanoylphorbol-13-Acetate. Skin Pharmacology. 2009:262-271. doi:10.1159/000210960

BibTeX
@article{Stanley2009,
  author = {Stanley, P L and Steiner, S and Havens, M and Tramposch, K M},
  title = {Mouse Skin Inflammation Induced by Multiple Topical Applications of 12-O-Tetradecanoylphorbol-13-Acetate},
  journal = {Skin Pharmacology},
  year = {2009},
  pages = {262--271},
  doi = {10.1159/000210960}
}
Kostenlos starten →